Ubiquitination‑deubiquitination in the Hippo signaling pathway (Review)
Authors:
Open Access
- 8 January 2019
- journal article
- review article
- Published by Spandidos Publications in Oncology Reports
- Vol. 41 (3) , 1455-1475
Abstract
The Hippo signaling pathway is considered to be a tissue growth regulator and tumor suppressor pathway that controls cell proliferation, differentiation, survival, regeneration and tissue homeostasis. Defects in Hippo kinases and hyperactivation of transcriptional co‑activator with PDZ‑binding motif and Yes‑associated protein (YAP) may contribute to the development of different types of cancer. The Hippo pathway is regulated in a variety of way, of which ubiquitination is of considerable importance. Ubiquitination is a crucial post‑translational protein modification in cancer cells and is an applicable target for pharmacological intervention. Ubiquitin modifications are involved in regulating various physiological processes and are counteracted by deubiquitination. Imbalanced ubiquitination‑deubiquitination is closely associated with tumor initiation and progression. Therefore, the examination of the specific association between the Hippo pathway and ubiquitination is of interest. The present study reviews the modulatory mechanism of ubiquitination‑deubiquitination in the Hippo signaling pathway, the recent progress in identifying therapeutic targets and strategies, and the future directions in the field that may contribute to better tumor diagnosis and treatment.Keywords
This publication has 215 references indexed in Scilit:
- Deubiquitinating enzymes in cellular signaling and disease regulationIUBMB Life, 2015
- Communication between host organism and cancer cells is transduced by systemic sphingosine kinase 1/sphingosine 1‐phosphate signalling to regulate tumour metastasisEMBO Molecular Medicine, 2012
- The socs box-adapting proteins for ubiquitination and proteasomal degradationIUBMB Life, 2012
- Hippo signaling in Drosophila: Recent advances and insightsDevelopmental Dynamics, 2011
- An RNAi screen identifies USP2 as a factor required for TNF‐α‐induced NF‐κB signalingInternational Journal of Cancer, 2011
- YAP1 and VGLL3, encoding two cofactors of TEAD transcription factors, are amplified and overexpressed in a subset of soft tissue sarcomasGenes, Chromosomes and Cancer, 2010
- NF-kB in development and progression of human cancerVirchows Archiv, 2005
- Ubiquitination and deubiquitination: Targeting of proteins for degradation by the proteasomeSeminars in Cell & Developmental Biology, 2000
- Structure, Expression, and Chromosome Mapping of LATS2, a Mammalian Homologue of the Drosophila Tumor Suppressor Gene lats/wartsGenomics, 2000
- Pez - A Novel Human cDNA Encoding Protein Tyrosine Phosphatase- and Ezrin-Like DomainsBiochemical and Biophysical Research Communications, 1995